Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent.

MLA

Rastogi, Anjay, et al. “Sodium Zirconium Cyclosilicate for the Management of Chronic Hyperkalemia in Kidney Disease, a Novel Agent.” Expert Review of Clinical Pharmacology, vol. 14, no. 9, Sept. 2021, pp. 1055–64. EBSCOhost, https://doi.org/10.1080/17512433.2021.1932460.

APA

Rastogi, A., Hanna, R. M., Mkrttchyan, A., Khalid, M., Yaqoob, S., Shaffer, K., Dhawan, P., Nobakht, N., Kamgar, M., Goshtaseb, R., Sarmosyan, K., Gnarini, M., Wassef, O., & Lerma, E. (2021). Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent. Expert Review of Clinical Pharmacology, 14(9), 1055–1064. https://doi.org/10.1080/17512433.2021.1932460

Chicago

Rastogi, Anjay, Ramy M Hanna, Anita Mkrttchyan, Maham Khalid, Sinan Yaqoob, Kelly Shaffer, Puneet Dhawan, et al. 2021. “Sodium Zirconium Cyclosilicate for the Management of Chronic Hyperkalemia in Kidney Disease, a Novel Agent.” Expert Review of Clinical Pharmacology 14 (9): 1055–64. doi:10.1080/17512433.2021.1932460.